A. Rosato et al., INDUCIBLE AND CONSTITUTIVE EXPRESSION OF RESISTANCE TO GLYCOPEPTIDES AND VANCOMYCIN DEPENDENCE IN GLYCOPEPTIDE-RESISTANT ENTEROCOCCUS-AVIUM, Antimicrobial agents and chemotherapy, 39(4), 1995, pp. 830-833
A clinical isolate of Enterococcus avium, Ea1, which exhibited inducib
le, low-level resistance to vancomycin and teicoplanin, and two mutant
s selected from this strain, Ea3 and Ea31, were studied, Ea3 was vanco
mycin dependent and derived from Ea1, while Ea31 was not vancomycin de
pendent, was constitutively resistant, and was derived from Ea3. Hybri
dization studies revealed that vanA was present in Ea1 and suggested t
hat it was located on a high-molecular-weight plasmid, Ln the absence
of induction, Ea1 synthesized only the natural UDP-MurNAc-pentapeptide
precursor, and after induction it synthesized an additional precursor
identified as UDP-MurNAc-tetrapeptide-D-lactate. The latter was the o
nly precursor found in Ea3 and Ea31, even after precursor accumulation
. From these results, we infer that (i) the low level of resistance to
glycopeptides in strain Ea1 may be in part due to the residual synthe
sis of the normal precursor and (ii) the vancomycin dependence of muta
nt Ea3 could be due to the fact that this strain does not produce any
peptidoglycan precursor in the absence of induction.